Jeffrey S. Heier - 17 Oct 2022 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Jeffrey S. Heier
Issuer symbol
OCUL
Transactions as of
17 Oct 2022
Transactions value $
$0
Form type
4
Filing time
18 Oct 2022, 17:12:45 UTC
Previous filing
21 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +16K $0.00 16K 17 Oct 2022 Common Stock 16K $4.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over four years, with 1/48 of the shares underlying the option vesting monthly beginning on August 1, 2022.